日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Author's Response to Comment on: Efficacy and safety of pilocarpine hydrochloride ophthalmic solution USP 1.25% w/v versus placebo ophthalmic solution for the treatment of presbyopia - A multicentric clinical trial

作者对以下评论的回应:盐酸毛果芸香碱滴眼液(USP 1.25% w/v)与安慰剂滴眼液治疗老花眼的疗效和安全性——一项多中心临床试验

Singh, Parul; Garasiya, Tejal; Ajila, Vidya; Sengupta, Sabyasachi; Datta, Aditi; Madhivanan, Nivean

Author's response Comments on: Efficacy and safety of pilocarpine hydrochloride ophthalmic solution USP 1.25% w/v (PresVu eye drops) versus placebo ophthalmic solution for the treatment of presbyopia - A multicentric clinical trial

作者回复评论:盐酸毛果芸香碱滴眼液 USP 1.25% w/v(PresVu 滴眼液)与安慰剂滴眼液治疗老花眼的疗效和安全性——一项多中心临床试验

Singh, Parul; Garasiya, Tejal; Ajila, Vidya; Sengupta, Sabyasachi; Datta, Aditi; Madhivanan, Nivean

Efficacy and safety of pilocarpine hydrochloride ophthalmic solution USP 1.25% w/v versus placebo ophthalmic solution for the treatment of presbyopia - A multicentric clinical trial

盐酸毛果芸香碱滴眼液(USP 1.25% w/v)与安慰剂滴眼液治疗老花眼的疗效和安全性比较——一项多中心临床试验

Singh, Parul; Garasiya, Tejal; Ajila, Vidya; Sengupta, Sabyasachi; Datta, Aditi; Nivean, M

Comparative analysis of two innovative products designed exclusively for sutureless scleral fixation of intraocular lenses, "XNIT device" versus "CM-T flex intraocular lens"

对两种专为无缝线巩膜固定人工晶状体而设计的创新产品“XNIT装置”与“CM-T flex人工晶状体”进行比较分析

Baskaran, Prabu; Madhivanan, Nivean; Sahu, Juhi; Mahalingam, Maanasi; Prabu, Seema; DNivean, Pratheeba; Abrar, Mohamed

Clinical results after binocular implantation of a unique nondiffractive enhanced monofocal intraocular lens designed for enhanced monovision to increase the depth of focus

一种独特的非衍射增强型单焦点人工晶状体,专为增强单视功能而设计,旨在增加景深,本文对双眼植入后的临床结果进行了评估。

Madhivanan, Nivean; Nivean, Pratheeba D; Madanagopalan, V G; Priya, Shanmuga; Madhivanan, Nishanth; Arthi, M

A novel two-surgeon technique of simultaneous bilateral cataract surgery with complete delinking

一种新型的双侧白内障同步手术技术,可实现完全分离

Madhivanan, Nishanth; Madhivanan, Nivean; Nishanth, Shruti; Nivean, Pratheeba Devi; Sekaran, Sangeetha; Malarkodi, S; Ramesh, Prasanna Venkatesh

Response to comments on: Efficacy of dorzolamide in improving ocular blood flow in patients with open-angle glaucoma: The Indian carbonic anhydrase inhibitor trial

对以下文章的评论回复:多佐胺改善开角型青光眼患者眼部血流的疗效:印度碳酸酐酶抑制剂试验

Ariga, Murali; Nivean, Pratheeba Devi

Silent sinus syndrome: A missed entity?

无症状性鼻窦炎:一种被忽视的疾病?

Nivean, Pratheeba Devi; Sayee, T S Mohammed; Nivean, M

Pseudoproptosis in a case of familial hereditary cerebellar ataxia

家族性遗传性小脑共济失调病例中的假性眼球突出

Nivean, Pratheeba D; Sayee, T S Mohammed; Madhivanan, Nivean

Changes in vergence and accommodation parameters after smartphone use in healthy adults

健康成年人使用智能手机后辐辏和调节参数的变化

Padavettan, Chitra; Nishanth, Shruti; Vidhyalakshmi, S; Madhivanan, Nishanth; Madhivanan, Nivean